Using a mobile phone in rural areas seems to pose a greater risk of developing brain tumours than it does in urban areas

NewsGuard 100/100 Score

Using a mobile phone in rural areas seems to pose a greater risk of developing brain tumours than it does in urban areas, suggests a Swedish study in Occupational and Environmental Medicine.

The findings are based on a sample of over 1400 adults aged between 20 and 80, living in the centre of Sweden. All of them had been diagnosed with a malignant or benign brain tumour between January 1997 and June 2000.

The group were compared with a similar number of healthy adults, matched for age and sex, and living in the same geographical area.

Daily mobile and cordless phone use was assessed, via questionnaire, which included a complete employment history.

How long users spent on the phone had little impact on the probability of being diagnosed with a brain tumour. But where they lived did make a difference for all phone types, and especially for mobile digital phones.

Residents of rural areas, who had been using a mobile digital phone for more than three years, were over three times as likely to be diagnosed with a brain tumour as those living in urban areas.

And digital mobile phone use for five years or more in a rural area quadrupled the risk compared with residency in urban areas.

For malignant brain tumours, the risk was eight times as high for those living in a rural area, but the numbers were small, caution the authors. No such effect was seen for analogue or cordless phones.

The authors reiterate that there is a difference in power output between mobile phones in urban and rural areas. This is because base stations tend to be much further apart in rural areas, requiring a higher signal intensity to compensate.

The compensatory system, known as the adaptive power control or APC, is used for mobile phone (GSM) networks.

Contact: Professor Lennart Hardell, Department of Oncology, University Hospital, Orebro, Sweden. Tel: +46 19 602 1000 Email: [email protected]

Click here to view the paper in full

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Unlocking glioblastoma's immune suppression mechanism